#Pharma #Bourse AstraZeneca to pay up to $1.15B for Pearl http://t.co/QxkIfv7PEg cc @ghabault
June 11, 2013
Publicité
/http%3A%2F%2Fmedia.philly.com%2Fimages%2F061013_AstraZeneca.jpg)
AstraZeneca to pay up to $1.15B for Pearl
Posted: Tuesday, June 11, 2013, 3:01 AM Drugmaker AstraZeneca P.L.C. said Monday that it had agreed to pay up to $1.15 billion for Pearl Therapeutics Inc., a privately held company based in Redwood City, Calif. Pearl's research focus is inhaled medication for respiratory diseases, specifically chronic obstructive pulmonary disease (COPD).